Abstract
The addition of human recombinant IFN-γ (102 and 103 IU/ml) inhibited human prostatic JCA-1 cell growth by 27% and '64%, respectively. Since the high dose of IFN-γ elicited an increase in G1 concomitant with a decrease in G2/M phases of the cell cycle, changes in the expression of cell cycle regulatory protein molecules were analyzed by Western blots. Results of these experiments show that IFN-γ down regulated the G1/S transition molecules, e.g., cyclin D1, the cyclin-dependent protein kinase Cdk4, and the retinoblastoma gene product (pRB), but increased the G2/M transition molecules, e.g., cyclin B1 and p34cdc2 (Cdk1). Possible modulation of Cdk-inhibitors (CDKIs), e.g., p53 and p21WAF1 which have checkpoint functions in the cell cycle, by IFN-γ, was also studied. The p53 was induced by both 102 and 103 IU/ml IFN-γ. At 103 IU/ml, IFN-γ inhibited p21WAF1, increased the expression of STATlα, and sustained the elevated STAT1α for up to 96 h. Thus several mechanisms may be involved in the antiproliferative effects of IFN-γ.
Original language | English |
---|---|
Pages (from-to) | 835-839 |
Number of pages | 5 |
Journal | International journal of oncology |
Volume | 10 |
Issue number | 4 |
Publication status | Published - 1997 Dec 1 |
Externally published | Yes |
Keywords
- Cyclin-dependent kinase inhibitors
- Cyclin-dependent kinases
- Cyclins
- IFN-
- Prostate cancer
- STAT1
ASJC Scopus subject areas
- Oncology
- Cancer Research